{
}
UBS has reduced its target price for Symrise from 128 to 121 euros while maintaining a "buy" rating. Analyst Charles Eden anticipates that upcoming quarterly figures will reveal lower organic sales growth than previously expected, although he believes the company's annual targets remain achievable. The adjustment in the price target is primarily attributed to a decline in industry valuation.
UBS has reduced its price target for Symrise from 128 to 121 euros while maintaining a "Buy" rating. Analyst Charles Eden anticipates lower organic sales growth in the upcoming quarterly figures but believes the company's annual targets remain achievable despite the industry's lower valuation.
UBS AG has maintained a "Buy" rating for Symrise shares, setting a price target of 133 euros, despite a 1.0% drop in share price to EUR 100.40. Analyst Charles Eden highlighted strong operating results and margin forecasts for 2025, although organic sales growth in Q4 fell short due to hyperinflation and exchange rate issues. The stock has seen a 2.2% decline since the start of 2025, with earnings figures for Q4 2024 expected on March 27, 2025.
UBS AG has maintained a "Buy" rating for Symrise shares, setting a price target of 133 euros. Analyst Charles Eden praised the company's operating results for the second half of the year, despite organic sales growth in Q4 falling short due to hyperinflation and exchange rate issues. Currently, Symrise shares are trading at 100.45 euros, reflecting a 0.9% decline, with a potential upside of 32.4% relative to the target price.
UBS has maintained a "Buy" rating for Symrise, setting a price target of 133 euros following the company's recent figures. Analyst Charles Eden expressed optimism about the operating results for the second half of the year and the margin forecast for 2025, despite organic sales growth in Q4 falling short due to hyperinflation and exchange rate issues.
UBS AG has maintained a "Buy" rating for Symrise, setting a price target of 133 euros, despite a 1.0% drop in share price to EUR 100.40. Analyst Charles Eden highlighted strong operating results and a positive margin forecast for 2025, although Q4 organic sales growth fell short due to hyperinflation and exchange rate issues. The share has a potential upside of 32.47% relative to the target price, with 230,036 shares traded so far.
UBS has maintained a 'Buy' rating for Symrise, setting a price target of 133 euros. Analyst Charles Eden expressed optimism about the company's operating results for the second half of the year and the margin forecast for 2025, despite organic sales growth in Q4 falling short due to hyperinflation and exchange rate issues.
UBS AG has reduced its price target for Givaudan shares from 4380 to 4310 Swiss francs while maintaining a "Neutral" rating. The adjustment reflects changes in estimates and a slight decline in industry valuation, with the stock currently trading at CHF 4,036.00, indicating a potential upside of 6.79%. Givaudan is set to release its Q2 2025 financial results on July 22, 2025.
UBS has reduced its price target for Givaudan from 4380 to 4310 Swiss francs while maintaining a "Neutral" rating. This adjustment reflects changes in estimates and a slight decline in industry valuation. The company's 2024 financial figures align with expectations, and discussions among investors are focused on volume trends for 2025.
Givaudan achieved a historic milestone in 2024, reporting net profits exceeding one billion Swiss francs for the first time, with a net profit of 1.09 billion francs and a revenue growth of 7.2% to 7.41 billion francs. Analysts have varied ratings, with Goldman Sachs maintaining a 'Buy' at 5100 francs, while Jefferies rates it 'Underperform' at 3400 francs. The company is set to release its financial figures for 2024 on January 24, 2025, amid mixed market reactions.
Charles Eden
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
UBS reduces Symrise price target to 121 euros while maintaining buy rating
10:11 31.03.2025
ubs lowers symrise price target but maintains buy rating
08:40 31.03.2025
ubs maintains buy rating for symrise with price target of 133 euros
12:29 30.01.2025
Symrise shares rated buy by UBS with price target of 133 euros
12:19 30.01.2025
UBS maintains buy rating for Symrise with price target of 133 euros
11:09 30.01.2025
ubs maintains buy rating for symrise with price target of 133 euros
10:58 30.01.2025
ubs maintains buy rating for symrise with positive margin outlook
10:09 30.01.2025
ubs lowers givaudan price target while maintaining neutral rating
15:48 28.01.2025
ubs lowers givaudan price target while maintaining neutral rating
13:39 28.01.2025
givaudan faces mixed analyst ratings as target prices fluctuate
Swiss Franc
JPMorgan Chase & Co.
The Goldman Sachs Group, Inc.
Givaudan SA
Baader Bank AG.
BERENBERG VARIATO
Barclays PLC
DEU
CHE
Charlie Bentley
Charles Eden
Georgina Fraser
Samantha Darbyshire
Chetan Udeshi
Celine Pannuti
Alex Sloane
Show more
12:39 28.01.2025
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Industry Mergers & Acquisitions
Finance Mergers & Acquisitions
Global Financial Events
Banking Regulations
Global Trade Developments
Domestic Politics
Retail and Consumer Goods
Central Bank Actions
CEO Changes
Government Policies
Workplace Trends
Market Analysis and Predictions
Startups & Entrepreneurship
Elections & Campaigns
Government Economic Policies
Inflation and Monetary Impact
Supply Chain Management
Countries:
Companies:
Tesla, Inc.
Barclays PLC
JPMorgan Chase & Co.
Deutsche Bank Money Market PP
Apple Inc.
UniCredit S.p.A.
Banco BPM S.p.A.
Credit Suisse Strategic Income I
The Goldman Sachs Group, Inc.
UBS Group AG
SpaceXCoin USD
BNP Paribas SA
Lloyds Banking Group plc
Banco Santander, S.A.
CREDIT AGRICOLE
Amazon.com, Inc.
Credit Agricole
Berkshire Hathaway Inc.
Reinsurance Group of America, Incorporated
Google Inc.
Currencies:
United States Dollar
Euro
British Pound Sterling
Swiss Franc
Chinese Yuan
Japanese Yen
Indian Rupee
South Korean Won
Canadian Dollar
Australian Dollar
Hong Kong Dollar
Offshore Chinese Yuan
Singapore Dollar
Mexican Peso
Vietnamese Đồng
Indonesian Rupiah
Thai Baht
Norwegian Krone
Swedish Krona
Filipino Peso
People: